CASTLE BIOSCIENCES INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Castle Biosciences Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2024.
  • Castle Biosciences Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $2.27M.
  • Castle Biosciences Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $6.08M.
  • Castle Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$57.5M, a 14.4% increase from 2022.
  • Castle Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$67.1M, a 115% decline from 2021.
  • Castle Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$31.3M, a 204% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.08M $2.27M +$9.17M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$3.1M $8.92M +$27.7M Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-04
Q1 2024 -$30.8M -$2.53M +$26.7M +91.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-04
Q4 2023 -$57.5M -$2.58M +$18M +87.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$75.5M -$6.91M +$13.3M +65.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$88.8M -$18.8M -$17.1M -1039% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-04
Q1 2023 -$71.7M -$29.2M -$4.58M -18.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-04
Q4 2022 -$67.1M -$20.6M -$14.2M -221% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$53M -$20.2M -$8.46M -71.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$44.5M -$1.65M +$7.14M +81.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 -$51.6M -$24.6M -$20.3M -475% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 -$31.3M -$6.43M -$1.54M -31.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$29.8M -$11.8M -$7.2M -157% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$22.5M -$8.79M -$7.42M -539% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-02
Q1 2021 -$15.1M -$4.28M -$4.85M -851% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-02
Q4 2020 -$10.3M -$4.89M -$6.94M -338% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$3.34M -$4.59M -$10.4M -178% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $7.1M -$1.38M -$107K -8.43% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 $7.21M $570K +$1.93M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 $5.28M $2.06M -$1.81M -46.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $7.09M $5.85M +$9.3M Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 -$2.21M -$1.27M +$1.89M +59.8% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 -$4.1M -$1.36M +$2.27M +62.6% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 -$6.37M $3.87M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$3.45M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-10
Q2 2018 -$3.16M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-10
Q1 2018 -$3.63M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.